Tag Archives: Biotech

Array’s colorectal cancer data shows why Pfizer splashed out $11B for the biotech

One key incentive for Pfizer paying $ 11 billion for Array BioPharma was the positive early readouts from its triplet therapy for colorectal cancer. Now, the biotech has shown exactly how attractive that data are. A combination of Array’s BRAF inhibitor Braftovi, its MEK inhibitor Mektovi and the anti-EGFR drug Erbitux significantly extended lives of previously-treated patients… Read More »

The Top Biotech and Medicine Advances to Expect in 2019 – Singularity Hub

2018 was bonkers for science. From a woman who gave birth using a transplanted uterus, to the infamous CRISPR baby scandal, to forensics adopting consumer-based genealogy test kits to track down criminals, last year was a factory churning out scientific “whoa” stories with consequences for years to come. With CRISPR still in the headlines, Britain… Read More »